Bicara Therapeutics Inc. Assets in USD from Q4 2023 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary
Bicara Therapeutics Inc. quarterly Assets history and growth rate from Q4 2023 to Q3 2025.
  • Bicara Therapeutics Inc. Assets for the quarter ending September 30, 2025 was $425M, a 19% decline year-over-year.
Assets, Quarterly (USD)
Assets, YoY Quarterly Growth (%)

Bicara Therapeutics Inc. Quarterly Assets (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $425M -$99.5M -19% Sep 30, 2025 10-Q 2025-11-10
Q2 2025 $454M Jun 30, 2025 10-Q 2025-08-12
Q1 2025 $478M Mar 31, 2025 10-Q 2025-05-13
Q4 2024 $510M +$276M +118% Dec 31, 2024 10-Q 2025-11-10
Q3 2024 $524M Sep 30, 2024 10-Q 2024-11-12
Q4 2023 $234M Dec 31, 2023 10-K 2025-03-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.